このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Sonic Healthcare 将来の成長

Future 基準チェック /16

Sonic Healthcare利益と収益がそれぞれ年間12.2%と5.3%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に8.9% 11.6%なると予測されています。

主要情報

12.2%

収益成長率

11.6%

EPS成長率

Healthcare 収益成長	19.8%
収益成長率	5.3%
将来の株主資本利益率	8.9%
アナリストカバレッジ	Good
最終更新日	29 May 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

CHIA:SHL - アナリストの将来予測と過去の財務データ ( )AUD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2026	9,757	651	940	1,437	14
6/30/2025	9,368	562	846	1,366	15
6/30/2024	8,840	493	695	1,180	15
12/31/2023	8,392	505	571	1,138	N/A
9/30/2023	8,281	595	772	1,304	N/A
6/30/2023	8,169	685	974	1,471	N/A
3/31/2023	8,417	850	1,260	1,721	N/A
12/31/2022	8,666	1,015	1,545	1,970	N/A
9/30/2022	9,003	1,238	1,696	2,098	N/A
6/30/2022	9,340	1,461	1,847	2,226	N/A
3/31/2022	9,209	1,463	1,885	2,249	N/A
12/31/2021	9,078	1,465	1,922	2,273	N/A
9/30/2021	8,916	1,390	1,801	2,158	N/A
6/30/2021	8,754	1,315	1,680	2,043	N/A
3/31/2021	8,339	1,133	1,492	1,840	N/A
12/31/2020	7,923	951	1,304	1,637	N/A
9/30/2020	7,378	739	1,170	1,498	N/A
6/30/2020	6,832	528	1,036	1,360	N/A
3/31/2020	6,703	554	827	1,187	N/A
12/31/2019	6,573	581	618	1,013	N/A
9/30/2019	6,353	565	540	930	N/A
6/30/2019	6,134	550	461	847	N/A
3/31/2019	5,952	510	452	816	N/A
12/31/2018	5,770	470	443	784	N/A
9/30/2018	5,655	473	442	776	N/A
6/30/2018	5,541	476	440	768	N/A
3/31/2018	5,430	468	429	762	N/A
12/31/2017	5,319	460	417	755	N/A
9/30/2017	5,220	444	N/A	746	N/A
6/30/2017	5,122	428	N/A	736	N/A
3/31/2017	5,081	444	N/A	726	N/A
12/31/2016	5,040	460	N/A	716	N/A
9/30/2016	5,029	456	N/A	712	N/A
6/30/2016	5,018	451	N/A	708	N/A
3/31/2016	4,829	406	N/A	647	N/A
12/31/2015	4,639	362	N/A	585	N/A
9/30/2015	4,420	355	N/A	549	N/A
6/30/2015	4,201	348	N/A	512	N/A
3/31/2015	4,115	365	N/A	540	N/A
12/31/2014	4,029	382	N/A	568	N/A
9/30/2014	3,971	383	N/A	562	N/A
6/30/2014	3,913	385	N/A	556	N/A
3/31/2014	3,799	373	N/A	517	N/A
12/31/2013	3,685	362	N/A	477	N/A
9/30/2013	3,585	348	N/A	468	N/A
6/30/2013	3,484	335	N/A	459	N/A

アナリストによる今後の成長予測

収入対貯蓄率: SHLの予測収益成長率 (年間12.2% ) は貯蓄率 ( 2.3% ) を上回っています。

収益対市場: SHLの収益 ( 12.2% ) Australian市場 ( 13.7% ) よりも低い成長が予測されています。

高成長収益: SHLの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: SHLの収益 ( 5.3% ) Australian市場 ( 5.4% ) よりも低い成長が予測されています。

高い収益成長: SHLの収益 ( 5.3% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: SHLの自己資本利益率は、3年後には低くなると予測されています ( 8.9 %)。

Sonic Healthcare 将来の成長

Future 基準チェック /16

主要情報

今後の成長に関する最新情報

Sonic Healthcare Limited Do Not Provide Earnings Guidance for the Fiscal Year 2021 Due to COVID-19

Recent updates

Sonic in the Running for Healius Imaging Business

New minor risk - Shareholder dilution

Upcoming dividend of AU$0.43 per share

First half dividend increased to AU$0.43

First half 2024 earnings released: EPS: AU$0.43 (vs AU$0.81 in 1H 2023)

Sonic Healthcare Limited to Report First Half, 2024 Results on Mar 20, 2024

Sonic Healthcare Limited (ASX:SHL) signed binding agreements to acquire Pathology Watch Inc. for $130 million.

Finance Director recently sold AU$1.3m worth of stock

Upcoming dividend of AU$0.62 per share at 3.2% yield

Sonic Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on 21 September, 2023

Full year 2023 earnings released: EPS: AU$1.46 (vs AU$3.06 in FY 2022)

Sonic Healthcare Limited to Report Fiscal Year 2023 Results on Aug 17, 2023

Now 20% undervalued after recent price drop

Sonic Healthcare Limited (ASX:SHL) signed an binding agreement to acquire synlab Suisse SA from SYNLAB International GmbH for CHF 150 million.

Upcoming dividend of AU$0.42 per share at 3.1% yield

First half 2023 earnings released

Sonic Healthcare Limited Announces Dividend for the Six Months Ended December 31, 2022, Payable on March 22, 2023

Sonic Healthcare Limited to Report First Half, 2023 Results on Feb 16, 2023

CEO, MD & Executive Director recently sold AU$9.9m worth of stock

Sonic Healthcare Limited Announces Board Changes

Sonic Healthcare Limited, Annual General Meeting, Nov 17, 2022

Sonic Healthcare Limited, Annual General Meeting, Nov 27, 2022

Upcoming dividend of AU$0.60 per share

Full year 2022 earnings released: EPS: AU$3.06 (vs AU$2.76 in FY 2021)

Sonic Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 21 September, 2022

Insufficient new directors

Upcoming dividend of AU$0.40 per share

Sonic Healthcare Limited (ASX:SHL) announces an Equity Buyback for AUD 500 million worth of its shares.

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Sonic Healthcare Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 23, 2022

Sonic Healthcare Limited (ASX:SHL) acquired ProPath Laboratory, Inc.

Full year 2021 earnings released: EPS AU$2.76 (vs AU$1.11 in FY 2020)

CEO, MD & Executive Director recently sold AU$8.4m worth of stock

Upcoming dividend of AU$0.55 per share

Full year 2021 earnings released: EPS AU$2.76 (vs AU$1.11 in FY 2020)

Sonic Healthcare Limited (ASX:SHL) signed a binding agreement to acquire Canberra Imaging Group.

Rhythm Biosciences Adds Sonic Clinical Services to Colostat Clinical Trial

New 90-day low: AU$31.39

First half 2021 earnings released: EPS AU$1.42 (vs AU$0.54 in 1H 2020)

Revenue beats expectations

Sonic Healthcare Limited to Report First Half, 2021 Results on Feb 18, 2021

Sonic Healthcare Limited to Report Fiscal Year 2021 Results on Aug 18, 2021

Sonic Healthcare Limited Elects Professor Suzanne Crowe as A Director

Sonic Healthcare Limited Do Not Provide Earnings Guidance for the Fiscal Year 2021 Due to COVID-19

Earnings released

New 90-day high - AU$34.66

Sonic Healthcare Limited to Report Fiscal Year 2020 Results on Aug 20, 2020

New 90-day high - AU$33.38

New 90-day high - AU$31.60

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘